Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs PayPal Holdings, Inc. — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.76 (market cap $6.04B), while PayPal Holdings, Inc. trades at $55.4 (market cap $47.07B). The key difference: PayPal Holdings, Inc. is far larger — about 7.8× Iovance Biotherapeutics Inc. Common Stock's market cap, and PayPal Holdings, Inc. pays a 1.02% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and PayPal Holdings, Inc. for 106 Days on average.
| IOVA | PYPL | |
|---|---|---|
Market Cap | $6.04B | $47.07B |
Volume | 14,805,993 | 13,860,099 |
Sector | Health | Financials |
52-Week High | $14.82 | $75.75 |
52-Week Low | $1.81 | $39.08 |
Typical Hold Time | 0 Days | 106 Days |
Enterprise Value | $5.97B | $49.21B |
Dividend Yield | — | 1.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PayPal (PYPL) trades at $55.47, up 0.95% today, with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals with a P/E of 10.4, net income margin of 14.36%, and consistent revenue growth from $33.17B in 2025 to $34.1B projected for 2026. Recent positive developments include a Meta partnership for AI-powered checkout and three consecutive quarterly earnings beats.
PYPL presents a compelling value opportunity with attractive valuation multiples and solid profitability, though investors face risks from checkout competition and slowing growth. Analyst consensus leans cautious with 60% hold ratings, but the $56.41 price target suggests modest upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
